 | • レポートコード：MRC308GR11568 • 出版社/出版日：GlobalInfoResearch / 2023年8月14日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のハンチントン病治療の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のハンチントン病治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– ハンチントン病治療の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
ハンチントン病治療市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・テトラベナジン、選択的セロトニン再取り込み阻害剤、クロルプロマジン、ハロペリドール、リスペリドン、オランザピン、クロザピン、その他
用途別セグメント
・病院、専門診療所、その他
主要な市場プレーヤー
・AInylam Pharmaceuticals Inc、AmpliPhi Biosciences Corp、Ceregene Inc、Lundbeck、Prana Biotechnology Limited、Teva Pharmaceutical Industries Ltd、Cortex Pharmaceuticals Inc、Vertex Pharmaceuticals Incorporated、Auspex Pharmaceuticals、SOM Biotech、GlaxoSmithKline、Siena Biotech、Raptor Pharmaceutical、Pfizer、Palobiofarma、Omeros、Ipsen、Valeant Pharmaceuticals International Inc
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、ハンチントン病治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なハンチントン病治療メーカーの企業概要、2019年～2022年までのハンチントン病治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なハンチントン病治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ハンチントン病治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのハンチントン病治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのハンチントン病治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびハンチントン病治療の産業チェーンを掲載しています。
・第14、15章では、ハンチントン病治療の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– ハンチントン病治療の概要
– 種類別分析（2018年vs2022年vs2029年）：テトラベナジン、選択的セロトニン再取り込み阻害剤、クロルプロマジン、ハロペリドール、リスペリドン、オランザピン、クロザピン、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、専門診療所、その他
– 世界のハンチントン病治療市場規模・予測
– 世界のハンチントン病治療生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– AInylam Pharmaceuticals Inc、AmpliPhi Biosciences Corp、Ceregene Inc、Lundbeck、Prana Biotechnology Limited、Teva Pharmaceutical Industries Ltd、Cortex Pharmaceuticals Inc、Vertex Pharmaceuticals Incorporated、Auspex Pharmaceuticals、SOM Biotech、GlaxoSmithKline、Siena Biotech、Raptor Pharmaceutical、Pfizer、Palobiofarma、Omeros、Ipsen、Valeant Pharmaceuticals International Inc
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：テトラベナジン、選択的セロトニン再取り込み阻害剤、クロルプロマジン、ハロペリドール、リスペリドン、オランザピン、クロザピン、その他
・用途別分析2018年-2029年：病院、専門診療所、その他
・ハンチントン病治療の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ハンチントン病治療のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ハンチントン病治療のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ハンチントン病治療の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ハンチントン病治療の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Huntington’s Disease Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Huntington’s Disease Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Tetrabenazine
1.3.3 Selective Serotonin Reuptake Inhibitor
1.3.4 Chlorpromazine
1.3.5 Haloperidol
1.3.6 Risperidone
1.3.7 Olanzapine
1.3.8 Clozapine
1.3.9 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Huntington’s Disease Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Specialty Clinic
1.4.4 other
1.5 Global Huntington’s Disease Treatment Market Size & Forecast
1.5.1 Global Huntington’s Disease Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Huntington’s Disease Treatment Sales Quantity (2018-2029)
1.5.3 Global Huntington’s Disease Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AInylam Pharmaceuticals Inc
2.1.1 AInylam Pharmaceuticals Inc Details
2.1.2 AInylam Pharmaceuticals Inc Major Business
2.1.3 AInylam Pharmaceuticals Inc Huntington’s Disease Treatment Product and Services
2.1.4 AInylam Pharmaceuticals Inc Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AInylam Pharmaceuticals Inc Recent Developments/Updates
2.2 AmpliPhi Biosciences Corp
2.2.1 AmpliPhi Biosciences Corp Details
2.2.2 AmpliPhi Biosciences Corp Major Business
2.2.3 AmpliPhi Biosciences Corp Huntington’s Disease Treatment Product and Services
2.2.4 AmpliPhi Biosciences Corp Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AmpliPhi Biosciences Corp Recent Developments/Updates
2.3 Ceregene Inc
2.3.1 Ceregene Inc Details
2.3.2 Ceregene Inc Major Business
2.3.3 Ceregene Inc Huntington’s Disease Treatment Product and Services
2.3.4 Ceregene Inc Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Ceregene Inc Recent Developments/Updates
2.4 Lundbeck
2.4.1 Lundbeck Details
2.4.2 Lundbeck Major Business
2.4.3 Lundbeck Huntington’s Disease Treatment Product and Services
2.4.4 Lundbeck Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lundbeck Recent Developments/Updates
2.5 Prana Biotechnology Limited
2.5.1 Prana Biotechnology Limited Details
2.5.2 Prana Biotechnology Limited Major Business
2.5.3 Prana Biotechnology Limited Huntington’s Disease Treatment Product and Services
2.5.4 Prana Biotechnology Limited Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Prana Biotechnology Limited Recent Developments/Updates
2.6 Teva Pharmaceutical Industries Ltd
2.6.1 Teva Pharmaceutical Industries Ltd Details
2.6.2 Teva Pharmaceutical Industries Ltd Major Business
2.6.3 Teva Pharmaceutical Industries Ltd Huntington’s Disease Treatment Product and Services
2.6.4 Teva Pharmaceutical Industries Ltd Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
2.7 Cortex Pharmaceuticals Inc
2.7.1 Cortex Pharmaceuticals Inc Details
2.7.2 Cortex Pharmaceuticals Inc Major Business
2.7.3 Cortex Pharmaceuticals Inc Huntington’s Disease Treatment Product and Services
2.7.4 Cortex Pharmaceuticals Inc Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cortex Pharmaceuticals Inc Recent Developments/Updates
2.8 Vertex Pharmaceuticals Incorporated
2.8.1 Vertex Pharmaceuticals Incorporated Details
2.8.2 Vertex Pharmaceuticals Incorporated Major Business
2.8.3 Vertex Pharmaceuticals Incorporated Huntington’s Disease Treatment Product and Services
2.8.4 Vertex Pharmaceuticals Incorporated Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Vertex Pharmaceuticals Incorporated Recent Developments/Updates
2.9 Auspex Pharmaceuticals
2.9.1 Auspex Pharmaceuticals Details
2.9.2 Auspex Pharmaceuticals Major Business
2.9.3 Auspex Pharmaceuticals Huntington’s Disease Treatment Product and Services
2.9.4 Auspex Pharmaceuticals Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Auspex Pharmaceuticals Recent Developments/Updates
2.10 SOM Biotech
2.10.1 SOM Biotech Details
2.10.2 SOM Biotech Major Business
2.10.3 SOM Biotech Huntington’s Disease Treatment Product and Services
2.10.4 SOM Biotech Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 SOM Biotech Recent Developments/Updates
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Huntington’s Disease Treatment Product and Services
2.11.4 GlaxoSmithKline Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 GlaxoSmithKline Recent Developments/Updates
2.12 Siena Biotech
2.12.1 Siena Biotech Details
2.12.2 Siena Biotech Major Business
2.12.3 Siena Biotech Huntington’s Disease Treatment Product and Services
2.12.4 Siena Biotech Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Siena Biotech Recent Developments/Updates
2.13 Raptor Pharmaceutical
2.13.1 Raptor Pharmaceutical Details
2.13.2 Raptor Pharmaceutical Major Business
2.13.3 Raptor Pharmaceutical Huntington’s Disease Treatment Product and Services
2.13.4 Raptor Pharmaceutical Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Raptor Pharmaceutical Recent Developments/Updates
2.14 Pfizer
2.14.1 Pfizer Details
2.14.2 Pfizer Major Business
2.14.3 Pfizer Huntington’s Disease Treatment Product and Services
2.14.4 Pfizer Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Pfizer Recent Developments/Updates
2.15 Palobiofarma
2.15.1 Palobiofarma Details
2.15.2 Palobiofarma Major Business
2.15.3 Palobiofarma Huntington’s Disease Treatment Product and Services
2.15.4 Palobiofarma Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Palobiofarma Recent Developments/Updates
2.16 Omeros
2.16.1 Omeros Details
2.16.2 Omeros Major Business
2.16.3 Omeros Huntington’s Disease Treatment Product and Services
2.16.4 Omeros Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Omeros Recent Developments/Updates
2.17 Ipsen
2.17.1 Ipsen Details
2.17.2 Ipsen Major Business
2.17.3 Ipsen Huntington’s Disease Treatment Product and Services
2.17.4 Ipsen Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Ipsen Recent Developments/Updates
2.18 Valeant Pharmaceuticals International Inc
2.18.1 Valeant Pharmaceuticals International Inc Details
2.18.2 Valeant Pharmaceuticals International Inc Major Business
2.18.3 Valeant Pharmaceuticals International Inc Huntington’s Disease Treatment Product and Services
2.18.4 Valeant Pharmaceuticals International Inc Huntington’s Disease Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Valeant Pharmaceuticals International Inc Recent Developments/Updates
3 Competitive Environment: Huntington’s Disease Treatment by Manufacturer
3.1 Global Huntington’s Disease Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Huntington’s Disease Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Huntington’s Disease Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Huntington’s Disease Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Huntington’s Disease Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Huntington’s Disease Treatment Manufacturer Market Share in 2022
3.5 Huntington’s Disease Treatment Market: Overall Company Footprint Analysis
3.5.1 Huntington’s Disease Treatment Market: Region Footprint
3.5.2 Huntington’s Disease Treatment Market: Company Product Type Footprint
3.5.3 Huntington’s Disease Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Huntington’s Disease Treatment Market Size by Region
4.1.1 Global Huntington’s Disease Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Huntington’s Disease Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Huntington’s Disease Treatment Average Price by Region (2018-2029)
4.2 North America Huntington’s Disease Treatment Consumption Value (2018-2029)
4.3 Europe Huntington’s Disease Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Huntington’s Disease Treatment Consumption Value (2018-2029)
4.5 South America Huntington’s Disease Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Huntington’s Disease Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Huntington’s Disease Treatment Sales Quantity by Type (2018-2029)
5.2 Global Huntington’s Disease Treatment Consumption Value by Type (2018-2029)
5.3 Global Huntington’s Disease Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Huntington’s Disease Treatment Sales Quantity by Application (2018-2029)
6.2 Global Huntington’s Disease Treatment Consumption Value by Application (2018-2029)
6.3 Global Huntington’s Disease Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Huntington’s Disease Treatment Sales Quantity by Type (2018-2029)
7.2 North America Huntington’s Disease Treatment Sales Quantity by Application (2018-2029)
7.3 North America Huntington’s Disease Treatment Market Size by Country
7.3.1 North America Huntington’s Disease Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Huntington’s Disease Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Huntington’s Disease Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Huntington’s Disease Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Huntington’s Disease Treatment Market Size by Country
8.3.1 Europe Huntington’s Disease Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Huntington’s Disease Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Huntington’s Disease Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Huntington’s Disease Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Huntington’s Disease Treatment Market Size by Region
9.3.1 Asia-Pacific Huntington’s Disease Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Huntington’s Disease Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Huntington’s Disease Treatment Sales Quantity by Type (2018-2029)
10.2 South America Huntington’s Disease Treatment Sales Quantity by Application (2018-2029)
10.3 South America Huntington’s Disease Treatment Market Size by Country
10.3.1 South America Huntington’s Disease Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Huntington’s Disease Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Huntington’s Disease Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Huntington’s Disease Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Huntington’s Disease Treatment Market Size by Country
11.3.1 Middle East & Africa Huntington’s Disease Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Huntington’s Disease Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Huntington’s Disease Treatment Market Drivers
12.2 Huntington’s Disease Treatment Market Restraints
12.3 Huntington’s Disease Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Huntington’s Disease Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Huntington’s Disease Treatment
13.3 Huntington’s Disease Treatment Production Process
13.4 Huntington’s Disease Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Huntington’s Disease Treatment Typical Distributors
14.3 Huntington’s Disease Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Huntington's Disease Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Huntington's Disease Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AInylam Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 4. AInylam Pharmaceuticals Inc Major Business
Table 5. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Product and Services
Table 6. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AInylam Pharmaceuticals Inc Recent Developments/Updates
Table 8. AmpliPhi Biosciences Corp Basic Information, Manufacturing Base and Competitors
Table 9. AmpliPhi Biosciences Corp Major Business
Table 10. AmpliPhi Biosciences Corp Huntington's Disease Treatment Product and Services
Table 11. AmpliPhi Biosciences Corp Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AmpliPhi Biosciences Corp Recent Developments/Updates
Table 13. Ceregene Inc Basic Information, Manufacturing Base and Competitors
Table 14. Ceregene Inc Major Business
Table 15. Ceregene Inc Huntington's Disease Treatment Product and Services
Table 16. Ceregene Inc Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Ceregene Inc Recent Developments/Updates
Table 18. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 19. Lundbeck Major Business
Table 20. Lundbeck Huntington's Disease Treatment Product and Services
Table 21. Lundbeck Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Lundbeck Recent Developments/Updates
Table 23. Prana Biotechnology Limited Basic Information, Manufacturing Base and Competitors
Table 24. Prana Biotechnology Limited Major Business
Table 25. Prana Biotechnology Limited Huntington's Disease Treatment Product and Services
Table 26. Prana Biotechnology Limited Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Prana Biotechnology Limited Recent Developments/Updates
Table 28. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 29. Teva Pharmaceutical Industries Ltd Major Business
Table 30. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Product and Services
Table 31. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 33. Cortex Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 34. Cortex Pharmaceuticals Inc Major Business
Table 35. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Product and Services
Table 36. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Cortex Pharmaceuticals Inc Recent Developments/Updates
Table 38. Vertex Pharmaceuticals Incorporated Basic Information, Manufacturing Base and Competitors
Table 39. Vertex Pharmaceuticals Incorporated Major Business
Table 40. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Product and Services
Table 41. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Vertex Pharmaceuticals Incorporated Recent Developments/Updates
Table 43. Auspex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Auspex Pharmaceuticals Major Business
Table 45. Auspex Pharmaceuticals Huntington's Disease Treatment Product and Services
Table 46. Auspex Pharmaceuticals Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Auspex Pharmaceuticals Recent Developments/Updates
Table 48. SOM Biotech Basic Information, Manufacturing Base and Competitors
Table 49. SOM Biotech Major Business
Table 50. SOM Biotech Huntington's Disease Treatment Product and Services
Table 51. SOM Biotech Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. SOM Biotech Recent Developments/Updates
Table 53. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 54. GlaxoSmithKline Major Business
Table 55. GlaxoSmithKline Huntington's Disease Treatment Product and Services
Table 56. GlaxoSmithKline Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. GlaxoSmithKline Recent Developments/Updates
Table 58. Siena Biotech Basic Information, Manufacturing Base and Competitors
Table 59. Siena Biotech Major Business
Table 60. Siena Biotech Huntington's Disease Treatment Product and Services
Table 61. Siena Biotech Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Siena Biotech Recent Developments/Updates
Table 63. Raptor Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Raptor Pharmaceutical Major Business
Table 65. Raptor Pharmaceutical Huntington's Disease Treatment Product and Services
Table 66. Raptor Pharmaceutical Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Raptor Pharmaceutical Recent Developments/Updates
Table 68. Pfizer Basic Information, Manufacturing Base and Competitors
Table 69. Pfizer Major Business
Table 70. Pfizer Huntington's Disease Treatment Product and Services
Table 71. Pfizer Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Pfizer Recent Developments/Updates
Table 73. Palobiofarma Basic Information, Manufacturing Base and Competitors
Table 74. Palobiofarma Major Business
Table 75. Palobiofarma Huntington's Disease Treatment Product and Services
Table 76. Palobiofarma Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Palobiofarma Recent Developments/Updates
Table 78. Omeros Basic Information, Manufacturing Base and Competitors
Table 79. Omeros Major Business
Table 80. Omeros Huntington's Disease Treatment Product and Services
Table 81. Omeros Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Omeros Recent Developments/Updates
Table 83. Ipsen Basic Information, Manufacturing Base and Competitors
Table 84. Ipsen Major Business
Table 85. Ipsen Huntington's Disease Treatment Product and Services
Table 86. Ipsen Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Ipsen Recent Developments/Updates
Table 88. Valeant Pharmaceuticals International Inc Basic Information, Manufacturing Base and Competitors
Table 89. Valeant Pharmaceuticals International Inc Major Business
Table 90. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Product and Services
Table 91. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Valeant Pharmaceuticals International Inc Recent Developments/Updates
Table 93. Global Huntington's Disease Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 94. Global Huntington's Disease Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Huntington's Disease Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 96. Market Position of Manufacturers in Huntington's Disease Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Huntington's Disease Treatment Production Site of Key Manufacturer
Table 98. Huntington's Disease Treatment Market: Company Product Type Footprint
Table 99. Huntington's Disease Treatment Market: Company Product Application Footprint
Table 100. Huntington's Disease Treatment New Market Entrants and Barriers to Market Entry
Table 101. Huntington's Disease Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Huntington's Disease Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 103. Global Huntington's Disease Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 104. Global Huntington's Disease Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Huntington's Disease Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Huntington's Disease Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 107. Global Huntington's Disease Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 108. Global Huntington's Disease Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Global Huntington's Disease Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Global Huntington's Disease Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Huntington's Disease Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Huntington's Disease Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 113. Global Huntington's Disease Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 114. Global Huntington's Disease Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Global Huntington's Disease Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Global Huntington's Disease Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Huntington's Disease Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Huntington's Disease Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 119. Global Huntington's Disease Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 120. North America Huntington's Disease Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 121. North America Huntington's Disease Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 122. North America Huntington's Disease Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 123. North America Huntington's Disease Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 124. North America Huntington's Disease Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 125. North America Huntington's Disease Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 126. North America Huntington's Disease Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Huntington's Disease Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Huntington's Disease Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 129. Europe Huntington's Disease Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 130. Europe Huntington's Disease Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 131. Europe Huntington's Disease Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 132. Europe Huntington's Disease Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 133. Europe Huntington's Disease Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 134. Europe Huntington's Disease Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Huntington's Disease Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Huntington's Disease Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 137. Asia-Pacific Huntington's Disease Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 138. Asia-Pacific Huntington's Disease Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 139. Asia-Pacific Huntington's Disease Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 140. Asia-Pacific Huntington's Disease Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 141. Asia-Pacific Huntington's Disease Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 142. Asia-Pacific Huntington's Disease Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Huntington's Disease Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Huntington's Disease Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 145. South America Huntington's Disease Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 146. South America Huntington's Disease Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 147. South America Huntington's Disease Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 148. South America Huntington's Disease Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 149. South America Huntington's Disease Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 150. South America Huntington's Disease Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Huntington's Disease Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Huntington's Disease Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 153. Middle East & Africa Huntington's Disease Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 154. Middle East & Africa Huntington's Disease Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 155. Middle East & Africa Huntington's Disease Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 156. Middle East & Africa Huntington's Disease Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 157. Middle East & Africa Huntington's Disease Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 158. Middle East & Africa Huntington's Disease Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Huntington's Disease Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Huntington's Disease Treatment Raw Material
Table 161. Key Manufacturers of Huntington's Disease Treatment Raw Materials
Table 162. Huntington's Disease Treatment Typical Distributors
Table 163. Huntington's Disease Treatment Typical Customers
List of Figures
Figure 1. Huntington's Disease Treatment Picture
Figure 2. Global Huntington's Disease Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Huntington's Disease Treatment Consumption Value Market Share by Type in 2022
Figure 4. Tetrabenazine Examples
Figure 5. Selective Serotonin Reuptake Inhibitor Examples
Figure 6. Chlorpromazine Examples
Figure 7. Haloperidol Examples
Figure 8. Risperidone Examples
Figure 9. Olanzapine Examples
Figure 10. Clozapine Examples
Figure 11. Other Examples
Figure 12. Global Huntington's Disease Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 13. Global Huntington's Disease Treatment Consumption Value Market Share by Application in 2022
Figure 14. Hospital Examples
Figure 15. Specialty Clinic Examples
Figure 16. other Examples
Figure 17. Global Huntington's Disease Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global Huntington's Disease Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Huntington's Disease Treatment Sales Quantity (2018-2029) & (K Units)
Figure 20. Global Huntington's Disease Treatment Average Price (2018-2029) & (US$/Unit)
Figure 21. Global Huntington's Disease Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 22. Global Huntington's Disease Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 23. Producer Shipments of Huntington's Disease Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 24. Top 3 Huntington's Disease Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Top 6 Huntington's Disease Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 26. Global Huntington's Disease Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 27. Global Huntington's Disease Treatment Consumption Value Market Share by Region (2018-2029)
Figure 28. North America Huntington's Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 29. Europe Huntington's Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 30. Asia-Pacific Huntington's Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 31. South America Huntington's Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 32. Middle East & Africa Huntington's Disease Treatment Consumption Value (2018-2029) & (USD Million)
Figure 33. Global Huntington's Disease Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 34. Global Huntington's Disease Treatment Consumption Value Market Share by Type (2018-2029)
Figure 35. Global Huntington's Disease Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 36. Global Huntington's Disease Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 37. Global Huntington's Disease Treatment Consumption Value Market Share by Application (2018-2029)
Figure 38. Global Huntington's Disease Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 39. North America Huntington's Disease Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 40. North America Huntington's Disease Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 41. North America Huntington's Disease Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 42. North America Huntington's Disease Treatment Consumption Value Market Share by Country (2018-2029)
Figure 43. United States Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Canada Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Mexico Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Europe Huntington's Disease Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 47. Europe Huntington's Disease Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 48. Europe Huntington's Disease Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 49. Europe Huntington's Disease Treatment Consumption Value Market Share by Country (2018-2029)
Figure 50. Germany Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. France Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. United Kingdom Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Russia Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Italy Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Asia-Pacific Huntington's Disease Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 56. Asia-Pacific Huntington's Disease Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 57. Asia-Pacific Huntington's Disease Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 58. Asia-Pacific Huntington's Disease Treatment Consumption Value Market Share by Region (2018-2029)
Figure 59. China Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Japan Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Korea Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. India Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Southeast Asia Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Australia Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. South America Huntington's Disease Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 66. South America Huntington's Disease Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 67. South America Huntington's Disease Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 68. South America Huntington's Disease Treatment Consumption Value Market Share by Country (2018-2029)
Figure 69. Brazil Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Argentina Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Middle East & Africa Huntington's Disease Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 72. Middle East & Africa Huntington's Disease Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 73. Middle East & Africa Huntington's Disease Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 74. Middle East & Africa Huntington's Disease Treatment Consumption Value Market Share by Region (2018-2029)
Figure 75. Turkey Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Egypt Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Saudi Arabia Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. South Africa Huntington's Disease Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 79. Huntington's Disease Treatment Market Drivers
Figure 80. Huntington's Disease Treatment Market Restraints
Figure 81. Huntington's Disease Treatment Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Huntington's Disease Treatment in 2022
Figure 84. Manufacturing Process Analysis of Huntington's Disease Treatment
Figure 85. Huntington's Disease Treatment Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source